abstract |
The invention provides compounds comprising at least one phosphoepoxide group of the formula: n n nwhere R1 is selected from among —CH 3 and —CH 2 —CH 3 . nCat+ is an organic or inorganic cation, n is an integer between 2 and 20, processes for the production thereof and uses thereof, in particular therapeutic uses and for activating primate Tγ9δ2 lymphocytes. |